6640--NEW - CTX Quant Studio 7 Pro Laboratory Equipment

Solicitation Description Solicitation No. 36C25726Q0816 Applied Biosystems QuantStudio 7 Pro Real-Time PCR System, or Equal Solicitation Number 36C25726Q0816 Contracting Office Department of Veterans Affairs, Network Contracting Office (NCO) 17, 5441 Babcock Road, Ste. 302, San Antonio, TX 78240 Contracting Officer Ognian D. Ivanov, Contracting Officer, Lab Support Team, Network Contracting Office 17 Requiring Activity VISN 17 Center of Excellence, 4800 Memorial Drive, Building 93, MRI W93, Waco, TX 76711 Place of Delivery/Performance Central Texas Veterans Health Care System, Olin E. Teague VA Hospital, Attn: Pathology Lab Med Svc., Temple, TX 76504 NAICS Code 334516 Analytical Laboratory Instrument Manufacturing Product/Service Code 6640 Laboratory Equipment and Supplies Small Business Size Standard 1,000 employees (NAICS 334516) Set-Aside Status Unrestricted / Full and Open Competition (Open Market) Acquisition Type Firm-Fixed-Price, Commercial Products and Commercial Services (FAR Part 12) Basis of Award Brand Name or Equal (FAR 52.211-6) Contract Structure Base period plus four (4) one-year option periods 1. DESCRIPTION OF REQUIREMENT The Department of Veterans Affairs, Network Contracting Office 17, on behalf of the VISN 17 Center of Excellence, intends to award a firm-fixed-price contract for the procurement of one (1) Applied Biosystems QuantStudio 7 Pro Real-Time PCR System, or equal, including all associated accessories, consumables, on-site training, and four (4) annual option-year preventive maintenance service agreements. The system will support RT-PCR research activities at the Central Texas Veterans Health Care System, Olin E. Teague VA Hospital, Temple, Texas, advancing research into biological and molecular differences between Veteran and civilian populations in support of personalized medicine initiatives. 2. TYPE OF SET-ASIDE This acquisition will be conducted on an UNRESTRICTED, FULL AND OPEN COMPETITION (OPEN MARKET) basis. In accordance with 38 U.S.C. §§ 8127 8128 and VAAR 819.7004, the Contracting Officer conducted market research and a Rule of Two analysis, which the Small Business Administration (SBA) has reviewed and approved, confirming that a reasonable expectation does not exist that offers would be received from two or more Veteran-Owned Small Businesses (VOSBs) or Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) capable of performing this brand-name-or-equal requirement at a fair and reasonable price. Accordingly, this solicitation is unrestricted and open to all responsible sources, consistent with FAR 6.101 and RFO FAR Part 6 policy favoring full and open competition. 3. BASIS OF ACQUISITION BRAND NAME OR EQUAL This solicitation is issued on a Brand Name or Equal basis under FAR 11.104 and FAR 52.211-6, incorporated in full at Section E.2 of the solicitation. The Applied Biosystems QuantStudio 7 Pro Real-Time PCR System (manufactured by Thermo Fisher Scientific) is cited solely to establish the minimum salient physical, functional, and performance characteristics required by the Government, and is not intended to restrict competition to that specific brand. Offerors proposing an equal product must demonstrate, through descriptive literature and a salient characteristics comparison, that the offered product meets or exceeds every characteristic identified in Section B.2, Section 4 of the Statement of Work. 4. APPLICABLE ACQUISITION AUTHORITY This procurement will be conducted using commercial product and commercial service acquisition procedures in accordance with FAR Part 12 and the corresponding provisions of the Revolutionary FAR Overhaul (RFO FAR), as implemented through the RFO FAR Commercial Checklist, applicable VA Acquisition Regulation (VAAR) deviations, and VA Acquisition Policy Flash 26-30. Where RFO FAR guidance has not yet superseded a legacy FAR provision or clause applicable to this acquisition, the corresponding FAR provision or clause remains in effect consistent with VA implementation memoranda directing that RFO FAR serve as guidance rather than the exclusive acquisition authority. 5. ESTIMATED PERIOD OF PERFORMANCE Base Period: One-time purchase, delivery, and installation of the laboratory instrumentation and initial training, with performance beginning on or about 08-31-2026 and concluding 08-30-2027. Option Periods: Four (4) consecutive one-year option periods (Option Year 1: 08-31-2027 08-30-2028; Option Year 2: 08-31-2028 08-30-2029; Option Year 3: 08-31-2029 08-30-2030; Option Year 4: 08-31-2030 08-30-2031) for annual preventive maintenance services, exercisable at the sole discretion of the Government pursuant to FAR 52.217-9. The total duration of the contract, including all exercised options, shall not exceed five (5) years. 6. EVALUATION AND AWARD BASIS Award will be made on a best-value or lowest-price technically acceptable basis, as specified in FAR 52.212-2, Evaluation Commercial Products and Commercial Services, incorporated at Se